Cytomel (Liothyronine) Cost in Maine 2026

What Does Cytomel (Liothyronine) Actually Cost in Maine Right Now?

Generic liothyronine is the most budget-friendly option for Maine patients in 2026, averaging $35 per month at retail pharmacies when paid out of pocket. Brand-name Cytomel carries a manufacturer list price of $120 per month, but almost no cash-paying patient pays that figure after discount cards are applied. Compounded liothyronine from a Maine-licensed 503A pharmacy sits at approximately $40 per month, which puts it slightly above the generic retail average but within reach for patients who need non-standard doses or specific release profiles.

Prices across Maine's retail chains vary by pharmacy and by the specific strength prescribed. A 30-tablet supply of 25 mcg liothyronine at a Walgreens or Hannaford pharmacy in Portland, Bangor, or Augusta typically falls between $28 and $42 using a free GoodRx coupon, depending on negotiated rates at that location. The 50 mcg and 5 mcg tablets often carry slightly different prices because pack-quantity economics differ across strengths. Patients prescribed twice-daily dosing may be splitting tablets, which can lower the per-dose cost further, though tablet splitting should only be done with a prescriber's guidance because liothyronine tablets are not scored at every strength.

Liothyronine has a narrow therapeutic index. Small changes in bioavailability between manufacturers can produce measurable shifts in free T3 levels, so clinicians generally recommend patients stay on the same manufacturer's product once stabilized 1. That clinical nuance means price-shopping between pharmacies sometimes conflicts with pharmacokinetic consistency, and prescribers may explicitly specify a preferred manufacturer on the prescription.

How the Brand vs. Generic Price Gap Works in Maine

Pfizer manufactures Cytomel, and its 2026 wholesale acquisition cost sits at roughly $120 per month for the 25 mcg tablet. Generic liothyronine from manufacturers such as Lannett, Mayne Pharma, and Jerome Stevens is therapeutically equivalent per FDA bioequivalence standards, and Maine pharmacies stock generics as the default dispensed product unless the prescriber writes "dispense as written" (DAW) or the patient requests the brand 2.

The FDA's therapeutic equivalence rating for generic liothyronine appears in the Orange Book under reference listed drug Cytomel. Switching between AB-rated generics mid-therapy is technically allowable, but endocrinologists often counsel against it in practice because T3's half-life of roughly 18 to 24 hours means even modest bioavailability differences become clinically apparent within days rather than weeks 3.

Maine does not have a mandatory generic substitution exception for thyroid drugs beyond the standard pharmacist substitution rules under Maine Revised Statutes Title 32, Chapter 117. A prescriber who wants to lock in a specific product writes DAW; otherwise the pharmacist may substitute freely.

Does MaineCare (Maine Medicaid) Cover Liothyronine?

Yes. MaineCare covers liothyronine sodium tablets for hypothyroidism as an adjunct therapy, but the plan requires a prior authorization (PA) for approval. The PA process asks the prescriber to document that levothyroxine (T4) monotherapy was tried and produced inadequate symptom control, or that a clinical reason exists for combination or T3-only therapy.

MaineCare's preferred drug list designates levothyroxine as the first-line thyroid drug. Liothyronine moves to a PA-required tier because the clinical evidence base for T3 supplementation, while growing, remains more contested than that for levothyroxine monotherapy 4. The Bunevicius et al. trial published in the New England Journal of Medicine (1999, N=33) reported that "substituting T3 for T4 may improve mood and neuropsychological function" in hypothyroid patients, providing a foundational rationale that prescribers commonly cite in PA submissions 5.

PA turnaround times for MaineCare average 3 to 5 business days for standard requests and 24 to 72 hours for expedited requests when the prescriber documents clinical urgency. Denials can be appealed through MaineCare's standard grievance process. Patients who need liothyronine while a PA is pending may obtain a 72-hour emergency supply at a Maine pharmacy under MaineCare rules if the drug is medically necessary.

Branded Cytomel is almost never covered as a preferred brand under MaineCare. The plan will approve generic liothyronine once the PA is granted.

Is Compounded Liothyronine T3 Legal in Maine?

Compounded liothyronine from a 503A pharmacy is legal in Maine when prescribed for an individual patient with a documented clinical need. The distinction matters. A 503A pharmacy compounds for individual patients on receipt of a valid prescription. A 503B outsourcing facility produces larger, anticipatory batches. Maine has licensed 503A compounding pharmacies, and some out-of-state 503A pharmacies are licensed to ship to Maine patients as long as they hold the appropriate non-resident pharmacy permit from the Maine Board of Pharmacy.

The FDA's 2013 Drug Quality and Security Act set the federal framework distinguishing 503A from 503B operations 6. Under 503A rules, compounders may not make copies of commercially available drugs without a clinical rationale. Because generic liothyronine is commercially available, a prescriber ordering compounded T3 should document why the commercial product is inadequate, such as a need for a sustained-release formulation, a different strength (for example, 37.5 mcg, which is not commercially produced), or an excipient allergy.

Compounded sustained-release liothyronine is the most frequently prescribed compounded form. Some clinicians believe sustained release better mimics physiologic T3 secretion, though no large randomized controlled trial has confirmed superiority over immediate-release liothyronine in terms of symptom outcomes 7. The American Thyroid Association's 2019 guidelines state that "the routine use of compounded T3 in thyroid hormone therapy cannot be recommended based on current evidence," while acknowledging that individual patients may benefit 7. That phrasing gives prescribers room to justify the PA documentation.

Pricing for compounded liothyronine from Maine-accessible 503A pharmacies runs approximately $40 per month for a standard sustained-release 25 mcg or 50 mcg daily dose. Specialty compounding pharmacies out of state that ship to Maine may charge anywhere from $35 to $80 per month depending on the formulation and compound complexity.

Which Private Insurance Plans Cover Liothyronine in Maine?

Most commercial insurance plans available through Maine's marketplace (CMS/ACA marketplace) and employer-sponsored plans cover generic liothyronine, typically at Tier 1 or Tier 2. Harvard Pilgrim, Anthem Blue Cross Blue Shield of Maine, and Community Health Options are the primary carriers operating in Maine. Each places generic liothyronine on formulary at a relatively low cost-share, often $10 to $20 per month after the deductible phase.

Branded Cytomel is almost uniformly placed at Tier 3 or Tier 4 on Maine commercial formularies, meaning patients pay 30% to 50% coinsurance or a fixed copay of $40 to $90 per month. Pfizer offers a savings card for commercially insured patients that can reduce out-of-pocket costs, but the card is not usable by patients with federal or state government insurance, including MaineCare or Medicare Part D. Patients on Medicare Part D should check their specific plan's formulary for liothyronine; most Part D plans cover generic liothyronine at low tiers, and the 2026 Part D redesign capped out-of-pocket drug costs at $2,000 per year for all covered drugs 8.

Patients who face a coverage gap or insurance denial should ask their prescriber to write a letter of medical necessity. For combination T4/T3 therapy, clinical documentation of persistent symptoms on T4 monotherapy, low free T3 labs, or genetic DIO2 polymorphism testing results may support the appeal.

Telehealth Prescribing of Liothyronine in Maine

Maine allows telehealth prescribing of liothyronine by licensed providers. The prescriber must hold a valid Maine medical license or qualify under the Interstate Medical Licensure Compact (IMLC), of which Maine is a member state. The Ryan Haight Online Pharmacy Consumer Protection Act requires that Schedule II through V controlled substances involve an in-person visit first, but liothyronine is not a controlled substance, so that restriction does not apply 9.

A telehealth provider evaluating a Maine patient for liothyronine should review recent thyroid panel labs (TSH, free T4, free T3, and ideally total T3), a history of levothyroxine adequacy or intolerance, and any cardiac history given that T3 raises heart rate and may exacerbate atrial fibrillation or angina at supraphysiologic doses. The American Association of Clinical Endocrinology (AACE) advises that T3-containing therapy requires closer TSH monitoring because liothyronine suppresses TSH more potently than equimolar levothyroxine 10.

HealthRX providers licensed in Maine can initiate or continue liothyronine therapy via asynchronous lab review and synchronous video visit. Labs ordered through HealthRX's partner networks are drawn at local collection sites throughout Maine, including Labcorp locations in Portland, Bangor, Brunswick, and Lewiston.

The Cheapest Way to Get Liothyronine in Maine in 2026

The lowest total monthly cost for most Maine cash-pay patients runs through one of three routes, and the right route depends on insurance status, dose, and whether a compounded formulation is required. Here is a concrete breakdown:

Route 1: GoodRx or RxSaver coupon plus generic at a Maine retail pharmacy. Patients present the coupon at the pharmacy counter instead of using insurance. Average cost: $28 to $42 per month for 25 mcg generic liothyronine (30 tablets). This route works at Walgreens, CVS, Hannaford, Walmart, and most independent Maine pharmacies. GoodRx prices fluctuate by zip code; patients in rural areas such as Presque Isle or Calais may see slightly higher prices than Portland.

Route 2: MaineCare with PA. For income-eligible patients, the net cost drops to $0 to $3.65 per prescription (Maine's Medicaid copay cap for non-preferred drugs). The cost of obtaining the PA falls on the prescriber's office, not the patient, though it does require clinical documentation.

Route 3: Maine Rx Plus and other state pharmacy assistance programs. Maine Rx Plus is Maine's state pharmaceutical assistance program for residents who do not qualify for Medicaid but have limited income. Eligible participants receive negotiated prices on a range of drugs, which may lower generic liothyronine costs below the GoodRx rate at participating pharmacies. Eligibility is income-based, and the program is administered through the Maine Department of Health and Human Services 11.

Patients on commercial insurance whose plan places generic liothyronine at Tier 1 will typically pay $0 to $15 per month after the plan year deductible is met, making insurance the cheapest option once coverage kicks in.

For patients who specifically need compounded sustained-release T3, no discount card applies. Pricing is set by the compounding pharmacy directly. Shopping three to four Maine-licensed or Maine-shipping 503A pharmacies by phone is the most reliable way to find the lowest compound price.

How GoodRx and Manufacturer Savings Cards Work in Maine

GoodRx functions as a pharmacy benefit manager that negotiates discounted rates with retail pharmacy chains. When a Maine patient presents a GoodRx card or app barcode at the pharmacy counter, the pharmacy bills GoodRx's contracted rate rather than the cash retail price. The discount is immediate. No application, no income verification. GoodRx is accepted at over 70,000 pharmacies nationally, including essentially all Maine chains.

The Pfizer savings card for Cytomel brand applies to commercially insured patients and may reduce copays to as low as $0 per month for eligible patients. The fine print excludes patients whose insurance is a federal or state government program. For a patient on a commercial plan paying a Tier 3 copay of $60 per month for branded Cytomel, the savings card could eliminate most of that cost. Patients should verify eligibility directly at Pfizer's patient assistance portal.

NeedyMeds.org lists additional manufacturer and independent assistance programs for liothyronine. Lannett and Mayne Pharma, two major generic manufacturers, do not typically offer branded savings programs, but their generic versions are already priced well below $50 per month at most Maine pharmacies even without a coupon.

One common mistake is patients using GoodRx when they should be running the claim through insurance, or vice versa. If a patient's plan deductible is already met, the insurance copay will often beat the GoodRx rate. If the deductible is not yet met, GoodRx frequently wins. Comparing both options at the pharmacy counter before the claim is run takes 30 seconds and can save $15 to $30 per fill.

Clinical Context: Why Some Maine Patients Are Prescribed Liothyronine

Standard care for hypothyroidism in the U.S. is levothyroxine (synthetic T4) monotherapy. The thyroid gland normally secretes both T4 and a smaller amount of T3 directly; peripheral conversion of T4 to T3 by deiodinase enzymes (DIO1, DIO2) supplies most circulating T3 in healthy individuals 13. Some patients carry a DIO2 polymorphism (Thr92Ala variant) that impairs this conversion, and they may remain symptomatic on levothyroxine despite a normal TSH 14.

The Bunevicius et al. 1999 trial (N=33, crossover design) compared levothyroxine monotherapy to a combination of levothyroxine plus 12.5 mcg liothyronine and found measurable improvements in mood, attention, and processing speed on the combination regimen 5. The trial was small, and larger subsequent studies produced mixed results, but the 1999 NEJM paper remains the most frequently cited justification for T3 supplementation in practice. The Jonklaas et al. ATA guidelines (2014) called for additional research but acknowledged that "a subset of hypothyroid patients may benefit from combination therapy" 15.

Liothyronine is also used as monotherapy in patients with thyroid cancer post-thyroidectomy who require TSH suppression and cannot tolerate levothyroxine, or as a short-term agent to reduce TSH during radioiodine scanning because its shorter half-life allows faster TSH recovery than levothyroxine 16.

Cardiac caution is real. T3 directly stimulates cardiac beta-1 receptors. Patients with pre-existing atrial fibrillation, angina, or recent myocardial infarction require careful dose titration, often starting at 5 mcg per day and increasing by 5 mcg increments every 2 to 4 weeks 16.

Monitoring Requirements and Refill Cadence in Maine

Once a patient is stable on liothyronine, most Maine prescribers check TSH and free T3 every 6 to 12 months. The initial titration phase, typically the first 3 to 6 months of therapy, usually requires labs at 6 to 8 week intervals because TSH suppression from liothyronine can appear within days of a dose change 16. Bone density monitoring is considered for patients maintained on TSH-suppressive doses long-term because chronic TSH suppression is associated with reduced bone mineral density, particularly in postmenopausal women 15.

Maine prescribers operating via telehealth generally require lab results before each refill during titration and may extend to annual labs once the patient is stable. HealthRX's standard liothyronine protocol requires a baseline thyroid panel, a 6-week follow-up free T3 and TSH, and then quarterly reviews for the first year.

Patients who use a 90-day mail-order pharmacy supply instead of monthly retail fills can reduce per-unit costs by 10% to 20% at many insurers and some cash-pay mail pharmacies. Generic liothyronine is stable at room temperature for the labeled shelf life; ask the dispensing pharmacist whether a 90-day supply is available for your specific strength, as some tablet strengths are dispensed in 30-count packaging only.

For patients who travel or split time between Maine and another state, liothyronine prescriptions written by a Maine-licensed provider are valid at any pharmacy in the U.S. provided the prescriber's DEA number (where applicable) and NPI are on file. Because liothyronine is not a controlled substance, interstate prescription transfers face fewer administrative barriers than Schedule II or III drugs.

The average Maine patient who is stable on 25 mcg generic liothyronine daily, uses a GoodRx coupon, and refills at a local Hannaford or Walmart pharmacy will pay approximately $35 per month or about $420 per year in 2026 cash-pay costs.